Related Experiment Video
Updated: Jan 31, 2026

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Sex-Specific Risk of Cardiovascular Disease in Autoimmune Addison Disease-A Population-Based Cohort Study
Jakob Skov1, Anders Sundström2, Jonas F Ludvigsson3
1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Insights
Cardiovascular disease (CVD) risk, particularly ischemic heart disease (IHD), is elevated in autoimmune Addison disease (AAD), especially for women. Higher glucocorticoid and mineralocorticoid doses correlate with increased CVD risk in women with AAD.
Area of Science:
- Endocrinology
- Cardiology
- Epidemiology
Background:
- Autoimmune Addison disease (AAD) is an endocrine disorder with limited known associations with cardiovascular disease (CVD).
- Inadequate glucocorticoid replacement therapy may potentially elevate CVD risk in AAD patients.
Purpose of the Study:
- To investigate the risk of CVD, specifically ischemic heart disease (IHD) and cerebrovascular disease (CeVD), in individuals with AAD.
- To explore the relationship between glucocorticoid and mineralocorticoid dosing and CVD risk in AAD patients.
Main Methods:
- A cohort-control study utilizing Swedish health registries from 1964 to 2013.
- Identification of 1500 AAD patients and 13,758 matched controls, with incident CVD analyzed from 2006 to 2013.
- Cox proportional hazard models were used to calculate adjusted hazard ratios (aHRs), with stratification of hormone replacement doses to assess dose-related risks.
Main Results:
- Patients with AAD experienced a higher incidence of CVD (10.7/1000 PY) compared to controls (7.0/1000 PY).
- Ischemic heart disease (IHD) risk was significantly increased in women with AAD (aHR, 2.15) but not in men (aHR, 1.16).
- No increased risk for cerebrovascular disease (CeVD) was observed in either sex. Higher glucocorticoid and mineralocorticoid doses were associated with increased CVD risk in women with AAD.
Conclusions:
- Autoimmune Addison disease is associated with an increased risk of IHD, particularly in women.
- The risk of CVD in women with AAD is independently correlated with higher doses of glucocorticoid and mineralocorticoid replacement.
- Close monitoring and proactive management of CVD risk factors are recommended for women with AAD.
Context:
Little is known of cardiovascular disease (CVD) in autoimmune Addison disease (AAD). Inadequate glucocorticoid replacement might potentially increase CVD risk.
Objective:
To examine CVD in AAD in subgroups of ischemic heart disease (IHD) and cerebrovascular disease (CeVD) and investigate the effects of glucocorticoid and mineralocorticoid dosing.
Design, Setting, And Patients:
In this cohort-control study, we used Swedish health registries from 1964 to 2013 to identify 1500 subjects with AAD and 13,758 matched controls. Incident CVD was analyzed from 2006 to 2013. Adjusted hazard ratios (aHRs) were calculated using Cox proportional hazard models. Glucocorticoid and mineralocorticoid doses were stratified to examine dose-related risks.
Results:
During 8807 person-years (PY), 94 events of first CVD (10.7/1000 PY) in patients with AAD occurred compared with 563 events during 80,163 PY (7.0/1000 PY) in controls. IHD was significantly more common in women (aHR, 2.15; 95% CI, 1.49 to 3.10) but not men (aHR, 1.16; 95% CI, 0.75 to 1.78) with AAD compared with controls. No increase in CeVD risk was detected (aHR, 0.88; 95% CI, 0.56 to 1.37, women; aHR, 0.88; 95% CI 0.53 to 1.50, men). CVD was associated with greater glucocorticoid and mineralocorticoid replacement doses in women but not men.
Conclusion:
The risk of IHD but not CeVD is increased in AAD, especially in women. The risk of CVD independently correlated with greater glucocorticoid and mineralocorticoid replacement doses in women. Our data suggest that close monitoring and early treatment of risk factors for CVD, among women in particular, might be warranted.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Conservation of Small Populations
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...

